Glioma-neuronal circuit remodeling induces regional immunosuppression

Area of Science:

• Neuroscience
• Immunology
• Oncology

Background:

• Glioblastoma (GBM) influences neuronal activity, and GBM cells can enhance neuronal connectivity.
• The impact of this enhanced connectivity on the tumor's immune microenvironment is not well understood.

Purpose of the Study:

• To investigate the link between enhanced neuronal connectivity in GBM and regional immunosuppression.
• To explore the role of Thrombospondin-1 (TSP1) in glioma-neuronal interactions and immune modulation.
• To assess the therapeutic potential of targeting glutamatergic signaling in GBM immunotherapy.

Main Methods:

• Analysis of immune cell composition and macrophage polarization in GBM regions with varying neuronal connectivity.
• Preclinical models using glioblastoma cells with and without Thrombospondin-1 (TSP1/Thbs1) knockout.
• Pharmacological inhibition of glutamatergic signaling in mouse models.
• Assessment of gene expression related to antigen presentation and immune cell infiltration.

Main Results:

• GBM regions with enhanced neuronal connectivity show regional immunosuppression, characterized by specific immune cell profiles and anti-inflammatory tumor-associated macrophages (TAMs).
• TSP1 knockout in GBM cells reduced synaptogenesis and neuronal hyperexcitability, restored antigen presentation genes, and promoted pro-inflammatory TAMs and CD8+ T-cell infiltration.
• Pharmacological inhibition of glutamatergic signaling shifted TAMs to a less immunosuppressive state, prolonged survival in mice, and indicated potential for enhancing immune-based therapies.

Conclusions:

• Glioma-induced neuronal circuit remodeling is closely associated with regional immunosuppression within the tumor microenvironment.
• Targeting the crosstalk between glioma cells, neurons, and immune cells, particularly by modulating glutamatergic signaling, offers a promising strategy for improving glioblastoma immunotherapy.